| Code | Description | Claims | Beneficiaries | Total Paid |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
25,732 |
22,497 |
$2.03M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,206 |
14,086 |
$1.78M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,154 |
5,624 |
$957K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,411 |
1,360 |
$781K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
3,354 |
3,043 |
$719K |
| G0378 |
Hospital observation service, per hour |
4,579 |
1,687 |
$476K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
1,650 |
1,484 |
$420K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,921 |
1,823 |
$378K |
| 59025 |
Fetal non-stress test |
5,718 |
3,906 |
$362K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,696 |
1,575 |
$356K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,115 |
4,016 |
$300K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
3,431 |
3,304 |
$256K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
4,743 |
4,418 |
$205K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,416 |
3,622 |
$188K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
5,300 |
5,056 |
$187K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,237 |
3,919 |
$177K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,554 |
2,301 |
$175K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,823 |
6,745 |
$171K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
28,031 |
21,893 |
$165K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,574 |
4,876 |
$155K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,379 |
1,982 |
$143K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,124 |
1,748 |
$135K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,645 |
4,565 |
$134K |
| 71046 |
Radiologic examination, chest; 2 views |
2,671 |
2,502 |
$134K |
| A0425 |
Ground mileage, per statute mile |
2,945 |
2,555 |
$125K |
| 71045 |
Radiologic examination, chest; single view |
7,268 |
6,504 |
$124K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,063 |
1,998 |
$109K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
18,027 |
14,581 |
$103K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,025 |
2,903 |
$99K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,010 |
1,702 |
$98K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,498 |
1,278 |
$94K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
337 |
315 |
$89K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,648 |
3,070 |
$84K |
| 80053 |
Comprehensive metabolic panel |
8,182 |
6,949 |
$80K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,322 |
2,078 |
$73K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
5,338 |
5,095 |
$70K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,558 |
3,403 |
$67K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,498 |
4,341 |
$66K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,836 |
3,542 |
$64K |
| 87507 |
|
316 |
300 |
$64K |
| 36415 |
Collection of venous blood by venipuncture |
32,395 |
24,707 |
$62K |
| D9420 |
|
51 |
51 |
$60K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
5,291 |
5,048 |
$59K |
| 87428 |
|
1,557 |
1,510 |
$57K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,817 |
1,701 |
$56K |
| 87088 |
|
9,682 |
8,833 |
$55K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
729 |
636 |
$51K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
730 |
585 |
$50K |
| 87660 |
|
3,650 |
3,360 |
$44K |
| 80076 |
|
10,903 |
9,372 |
$44K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
556 |
530 |
$43K |
| 74018 |
|
987 |
944 |
$42K |
| 87480 |
|
3,448 |
3,240 |
$42K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
520 |
511 |
$41K |
| 87581 |
|
3,491 |
3,363 |
$41K |
| 87510 |
|
3,448 |
3,240 |
$41K |
| 87486 |
|
3,491 |
3,363 |
$40K |
| 87506 |
|
461 |
446 |
$40K |
| 81001 |
|
17,513 |
15,227 |
$37K |
| 84703 |
|
9,897 |
8,931 |
$36K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,678 |
3,573 |
$29K |
| 80061 |
Lipid panel |
2,111 |
2,044 |
$25K |
| 87631 |
|
550 |
535 |
$25K |
| 86901 |
|
2,088 |
1,889 |
$23K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
808 |
792 |
$22K |
| 83690 |
|
6,392 |
5,664 |
$22K |
| 84484 |
|
4,170 |
3,067 |
$21K |
| 84702 |
|
4,074 |
3,456 |
$21K |
| 84439 |
|
2,250 |
2,183 |
$20K |
| 87077 |
|
2,992 |
2,653 |
$19K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
315 |
287 |
$17K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,607 |
1,563 |
$17K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,000 |
1,950 |
$17K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
612 |
578 |
$16K |
| 99215 |
Prolong outpt/office vis |
211 |
200 |
$16K |
| 88142 |
|
1,069 |
1,049 |
$16K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
97 |
95 |
$15K |
| 82728 |
|
1,137 |
1,110 |
$15K |
| 87186 |
|
2,216 |
2,016 |
$15K |
| 96376 |
|
252 |
187 |
$15K |
| 85027 |
|
2,053 |
1,723 |
$15K |
| 73630 |
|
375 |
366 |
$14K |
| 83735 |
|
2,320 |
1,812 |
$14K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
42 |
38 |
$13K |
| 82607 |
|
957 |
930 |
$13K |
| 95816 |
|
77 |
75 |
$13K |
| 87081 |
|
2,385 |
2,304 |
$13K |
| 87420 |
|
1,227 |
1,159 |
$13K |
| 87040 |
|
1,375 |
984 |
$12K |
| 84112 |
|
180 |
167 |
$11K |
| 73130 |
|
352 |
344 |
$11K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
376 |
351 |
$10K |
| 80329 |
|
673 |
361 |
$10K |
| 85730 |
|
2,113 |
1,890 |
$10K |
| 86850 |
|
960 |
872 |
$10K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
44 |
42 |
$8K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
29 |
27 |
$8K |
| 86003 |
|
266 |
203 |
$8K |
| 86696 |
|
534 |
505 |
$8K |
| 73610 |
|
314 |
301 |
$8K |
| 85610 |
|
2,415 |
2,088 |
$8K |
| 86900 |
|
2,089 |
1,888 |
$8K |
| 87070 |
|
848 |
802 |
$7K |
| 85007 |
|
2,102 |
1,744 |
$7K |
| 82947 |
|
1,842 |
1,375 |
$7K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
466 |
449 |
$7K |
| 87340 |
|
770 |
741 |
$7K |
| 86140 |
|
1,305 |
1,148 |
$7K |
| 0001A |
|
227 |
219 |
$6K |
| 83540 |
|
830 |
778 |
$6K |
| 83615 |
|
1,145 |
978 |
$6K |
| 83550 |
|
639 |
624 |
$6K |
| J2704 |
Injection, propofol, 10 mg |
2,550 |
1,974 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,596 |
3,336 |
$5K |
| 82746 |
|
355 |
348 |
$5K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,453 |
2,246 |
$5K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
80 |
63 |
$4K |
| 73560 |
|
126 |
126 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
226 |
224 |
$4K |
| 80320 |
|
626 |
589 |
$4K |
| 86695 |
|
535 |
506 |
$4K |
| 0002A |
|
117 |
117 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,257 |
1,008 |
$4K |
| 82247 |
|
662 |
551 |
$4K |
| 86592 |
|
1,342 |
1,285 |
$4K |
| 87045 |
|
237 |
209 |
$4K |
| 72082 |
|
41 |
41 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,846 |
4,523 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,069 |
3,374 |
$3K |
| 73110 |
|
102 |
99 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,312 |
1,895 |
$3K |
| 82553 |
|
351 |
287 |
$3K |
| 80069 |
|
336 |
288 |
$3K |
| 82550 |
|
672 |
550 |
$3K |
| 99201 |
|
114 |
113 |
$3K |
| 94770 |
|
80 |
77 |
$3K |
| 72100 |
|
55 |
54 |
$3K |
| 85652 |
|
961 |
885 |
$3K |
| 86703 |
|
501 |
482 |
$3K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
32 |
26 |
$3K |
| J1756 |
Injection, iron sucrose, 1 mg |
59 |
25 |
$3K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,127 |
902 |
$3K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
23 |
12 |
$3K |
| 73030 |
|
79 |
79 |
$2K |
| 86762 |
|
268 |
252 |
$2K |
| 82105 |
|
127 |
125 |
$2K |
| 96367 |
|
48 |
26 |
$2K |
| 81003 |
|
1,056 |
1,015 |
$2K |
| 82785 |
|
95 |
95 |
$2K |
| 84460 |
|
359 |
309 |
$2K |
| 84450 |
|
359 |
309 |
$2K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
476 |
399 |
$2K |
| 87653 |
|
93 |
90 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
40 |
38 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
15 |
15 |
$2K |
| 83020 |
|
270 |
254 |
$2K |
| 85378 |
|
358 |
337 |
$2K |
| 73090 |
|
59 |
55 |
$2K |
| 85384 |
|
210 |
168 |
$2K |
| 84478 |
|
318 |
270 |
$2K |
| 84156 |
|
501 |
392 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
665 |
503 |
$2K |
| 76830 |
Ultrasound, transvaginal |
42 |
42 |
$2K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
2,874 |
2,563 |
$2K |
| 84560 |
|
308 |
261 |
$2K |
| 82950 |
|
301 |
298 |
$2K |
| 82465 |
|
328 |
280 |
$2K |
| 83605 |
|
215 |
186 |
$1K |
| 84550 |
|
312 |
258 |
$1K |
| 88304 |
|
61 |
55 |
$1K |
| 10060 |
|
12 |
12 |
$1K |
| 84155 |
|
335 |
285 |
$1K |
| 83021 |
|
270 |
254 |
$1K |
| 86803 |
|
163 |
158 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
36 |
34 |
$1K |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
352 |
288 |
$1K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
48 |
28 |
$1K |
| 0352U |
|
314 |
303 |
$1K |
| 82977 |
|
195 |
158 |
$1K |
| 12011 |
|
13 |
12 |
$942.32 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
528 |
425 |
$918.59 |
| 82784 |
|
54 |
51 |
$913.79 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
571 |
507 |
$912.32 |
| 84100 |
|
254 |
181 |
$903.46 |
| 80143 |
|
234 |
219 |
$900.05 |
| 82570 |
|
193 |
177 |
$889.85 |
| 80179 |
|
229 |
215 |
$883.37 |
| 83001 |
|
41 |
40 |
$877.50 |
| 83874 |
|
78 |
59 |
$817.67 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,134 |
1,754 |
$796.75 |
| 86738 |
|
47 |
45 |
$747.58 |
| 87046 |
|
238 |
209 |
$687.69 |
| 85014 |
|
283 |
272 |
$670.99 |
| 85018 |
|
261 |
250 |
$649.69 |
| 74022 |
|
15 |
14 |
$631.23 |
| 83002 |
|
25 |
25 |
$587.10 |
| 76641 |
|
13 |
12 |
$578.68 |
| 83516 |
|
36 |
27 |
$552.70 |
| 87205 |
|
184 |
174 |
$539.57 |
| 72081 |
|
14 |
14 |
$512.15 |
| J7510 |
Prednisolone oral, per 5 mg |
382 |
350 |
$475.90 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
783 |
589 |
$471.89 |
| 82043 |
|
66 |
65 |
$469.20 |
| 86039 |
|
32 |
30 |
$444.45 |
| 29105 |
|
12 |
12 |
$419.95 |
| 73070 |
|
12 |
12 |
$396.45 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
137 |
52 |
$361.07 |
| 87338 |
|
15 |
15 |
$279.06 |
| 80354 |
|
82 |
80 |
$266.17 |
| 70320 |
|
51 |
51 |
$263.76 |
| 0071A |
|
20 |
17 |
$223.75 |
| 83525 |
|
24 |
24 |
$209.17 |
| J1644 |
Injection, heparin sodium, per 1000 units |
332 |
160 |
$197.27 |
| 87177 |
|
15 |
15 |
$158.77 |
| 82575 |
|
14 |
14 |
$158.07 |
| 87807 |
|
31 |
30 |
$151.83 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
289 |
196 |
$150.33 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
319 |
175 |
$92.31 |
| 82150 |
|
12 |
12 |
$84.02 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
28 |
13 |
$78.66 |
| 83655 |
|
14 |
14 |
$55.95 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
14 |
14 |
$55.64 |
| 80345 |
|
13 |
12 |
$40.35 |
| 84132 |
|
20 |
12 |
$29.78 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
45 |
43 |
$19.27 |
| 36416 |
|
49 |
44 |
$9.60 |
| 81015 |
|
60 |
54 |
$4.27 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
15 |
14 |
$2.92 |